NEW YORK, August 22, 2017 /PRNewswire/ --
If you want a Stock Review on WBMD, MTBC, EVH, or CERN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Healthcare Information Services are constantly evolving, but generally speaking, these services include software solutions, clinical content, hardware, and devices that offer health care providers secure access to clinical, administrative, and financial data that can be used to boost quality, improve safety, and increase efficiency across the sector. For today, DailyStockTracker.com takes note of the following companies in this space: WebMD Health Corp. (NASDAQ: WBMD), Medical Transcription Billing Corp. (NASDAQ: MTBC), Evolent Health Inc. (NYSE: EVH), and Cerner Corp. (NASDAQ: CERN). Daily Stock Tracker provides great insights on these stocks in its free research reports at:
New York headquartered WebMD Health Corp.'s shares saw a slight drop of 0.06%, finishing Monday's trading session at $66.24. A total volume of 1.01 million shares was traded. In the last month and the previous three months, the stock has advanced 20.02% and 17.51%, respectively. Additionally, the Company's shares have gained 33.63% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 8.28% and 21.10%, respectively. Moreover, shares of WebMD Health have a Relative Strength Index (RSI) of 72.71.
On July 25th, 2017, research firm SunTrust downgraded the Company's stock rating from 'Buy' to 'Hold'.
On August 07th, 2017, WebMD Health provided notice that, pursuant to the terms of its 2018, 2020, and 2023 indentures, the Company anticipates that a Make-Whole Fundamental Change (as such term is defined in the 2020 Indenture and the 2023 Indenture) and a Make Whole Change of Control (as such term is defined in the 2018 Indenture) may occur on or after September 07th, 2017, as a result of its previously announced tender offer. Free research report on WBMD is available at:
Medical Transcription Billing
On Monday, shares in New Jersey headquartered Medical Transcription Billing Corp. recorded a trading volume of 224,476 shares, and ended the session 2.78% lower at $1.40. The stock has gained 16.67% in the last one month and 93.10% on an YTD basis. The Company's shares are trading 27.51% above their 200-day moving average. Furthermore, shares of the company, which provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily, have an RSI of 48.91.
On August 17th, 2017, Medical Transcription Billing announced that it will be presenting at the Rodman & Renshaw 19th Annual Global Investment Conference, to be held on September 10th, 2017 to September 12th, 2017, at the Lotte New York Palace Hotel in New York. The Company presentation will occur on September 11th, 2017, at 4:40 p.m. EDT in the Adams Room. The complimentary research report on MTBC can be downloaded at:
Shares in Virginia headquartered Evolent Health Inc. closed at $17.25, up 1.17% from the last trading session. The stock recorded a trading volume of 1.20 million shares. The Company's shares have gained 16.55% since the start of this year. The stock is trading 18.40% below its 200-day moving average. Additionally, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions, have an RSI of 22.54.
On August 07th, 2017, Evolent Health announced its partnership with Crystal Run Healthcare, one of the fastest-growing, multi-specialty group practices in the US. The former will power the New York based, provider-sponsored Crystal Run Health Plan. It will also provide Third Party Administrator services and population health management technology for Crystal Run's Medicaid and commercial health plans. Visit DailyStockTracker.com today and access our complete research report on EVH at:
Missouri headquartered Cerner Corp.'s stock ended 1.06% higher at $64.93. A total volume of 1.80 million shares was traded, which was above their three months average volume of 1.73 million shares. The Company's shares have advanced 0.54% over the previous three months and 37.07% on an YTD basis. The stock is trading slightly above its 200-day moving average by 12.02%. Furthermore, shares of Cerner have an RSI of 54.07.
On July 27th, 2017, Cerner announced results for Q2 2017 ended July 01st, 2017. For Q2 2017, bookings were $1.636 billion; revenue was $1.292 billion; GAAP net earnings were $179.7 million; and adjusted net earnings were $205.5 million. For the quarter, operating cash flow was $292.2 million; free cash flow was $119.1 million; and total backlog was $16.648 billion.
On August 10th, 2017, research firm Morgan Stanley upgraded the Company's stock rating from 'Underweight' to 'Equal-Weight'. Get free access to your research report on CERN at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA